ValiRx plc (LON:VAL – Get Free Report)’s stock price rose 22.8% during mid-day trading on Wednesday . The company traded as high as GBX 0.18 and last traded at GBX 0.18. Approximately 33,947,781 shares traded hands during mid-day trading, an increase of 221% from the average daily volume of 10,563,343 shares. The stock had previously closed at GBX 0.14.
ValiRx Trading Down 5.6%
The company has a market cap of £1.99 million, a P/E ratio of -0.28 and a beta of 0.59. The company has a current ratio of 4.62, a quick ratio of 1.27 and a debt-to-equity ratio of 0.05. The business has a 50 day moving average price of GBX 0.19 and a 200-day moving average price of GBX 0.28.
ValiRx (LON:VAL – Get Free Report) last posted its quarterly earnings results on Monday, June 22nd. The company reported GBX (0.54) EPS for the quarter. ValiRx had a negative return on equity of 70.79% and a negative net margin of 7,115.36%.The business had revenue of GBX 3 million for the quarter. Analysts forecast that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Read More
- Five stocks we like better than ValiRx
- Has Broadcom Become Too Expensive for Its AI Story?
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
